no weight loss with tirzepatide Why Am I Not Losing on Tirzepatide? Microdosing tirzepatide gets misunderstood a

Nevertheless, unimolecular GIPGLP-1 co-agonism is an effective therapy for type 2 diabetes, associated with weight loss and reduction of fat mass, in rats, mice, monkeys and humans [66]

Bone Density Considerations Rapid weight loss can affect bone density, and women are more vulnerable to this than men due to lower baseline bone mass

Furthermore, an absence of GPR120, results in an overactive glucagon signaling, explaining the hyperglycaemia (282)

Potential Benefits of Retatrutide Early clinical data suggest several promising benefits: Significant Weight Loss : In a Phase 3 trial, participants receiving 12 mg of Retatrutide weekly lost an average of 28.7% of their body weight over 68 weeks, outperforming semaglutide-based therapies